Hormonal contraception
320 results
201 - 300
Oestrogens and progestins for preventing and treating postpartum depression: Cochrane systematic review- Combination contraceptives: effects on weight: Cochrane systematic review
Sterilization - Levonorgestrel intrauterine system vs. other forms of reversible contraceptives
- Combined oral contraceptive pills for treatment of acne
Oral contraceptives increase risk of thrombotic stroke and MI- Laparoscopic surgery for pelvic pain associated with endometriosis: Cochrane systematic review
- Skin colour changes and pigmentary disorders
- Skin patch and vaginal ring versus combined oral contraceptives for contraception: Cochrane systematic review
- Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery
- Contraceptive implant and LNG-IUD both reduce pelvic pain associated with endometriosis
- Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne: Cochrane systematic review
- Theory‐based interventions for contraception
- Bariatric surgery associated with resolution of endometrial hyperplasia
- Oral contraceptive pill, progestogen or oestrogen pretreatment for ovarian stimulation protocols for women undergoing assisted reproductive techniques
- Triphasic versus monophasic oral contraceptives for contraception: Cochrane systematic review
- Subdermal implants for contraception
- DMPA associated with reduced risk for ovarian cancer
- Dysmenorrhoea
- Laparoscopic surgery for subfertility associated with endometriosis: Cochrane systematic review
- OC use associated with reduction in ovarian cancer risk
- Interventions for heavy menstrual bleeding; overview of Cochrane reviews and network meta‐analysis
- Gonadotrophin-releasing hormone analogues for endometriosis: bone mineral density
- Skin problems in people with dark skin
- Combined oral contraceptives for polycystic ovary syndrome
- Quadriphasic versus monophasic oral contraceptives for contraception
- Adenomyosis
- Gonadotrophin-releasing hormone analogues for pain associated with endometriosis: Cochrane systematic review
- Abnormal menstrual bleeding
- Ovulation suppression for endometriosis for women with subfertility
- Amenorrhoea
- Postpartum IUD placement at 2-4 wk = 6-8 wk, with caveats
- Risk of venous thromboembolism in users of combined contraceptives
- Elagolix with add-back therapy effective for premenopausal heavy menstrual bleeding associated with fibroids
- Prophylactic salpingo-oophorectomy reduces ovarian cancer risk
- Porphyrias
- Pap (cervical) smear and endometrial biopsy
- Topiramate for the prophylaxis of episodic migraine in adults
- A patient with intellectual disability (ID) in a medical consultation
- Metformin versus the combined oral contraceptive pill for hirsutism, acne, and menstrual pattern in polycystic ovary syndrome
- Oral contraceptives for pain associated with endometriosis
- Network analysis finds oral isotretinoin most effective for acne vulgaris
- Cyclical progestogens for heavy menstrual bleeding
- Antenatal clinics: care and examinations
- Interventions for preventing unintended pregnancies among adolescents
- Progestagens and anti‐progestagens for pain associated with endometriosis
- Ischaemic stroke and myocardial infarction risk with combined oral contraceptives
- Gonadotrophin‐releasing hormone analogues for pain associated with endometriosis
- Prevention of venous thromboembolism
- Duration of vasomotor symptoms can be quite long during menopause
- Hair loss and balding
- Non‐contraceptive oestrogen‐containing preparations for controlling symptoms of premenstrual syndrome
- Long acting progestin contraceptives and bone mineral density
- Selective oestrogen receptor modulators (SERMs) for endometriosis
- Progestogens or progestogen‐releasing intrauterine systems for uterine fibroids (other than preoperative medical therapy)
- Gabapentin ineffective for vulvodynia
- Migraine with aura associated with increased risk of CVD in women
- Saffron promising for treatment of PMS
- Benign gynaecological lesions and tumours
- Turner syndrome
- Combined oral contraceptives and bone mineral density
- Interventions for pain with intrauterine device insertion
- Oral contraceptives containing drospirenone for premenstrual syndrome
- Gonadotrophin‐releasing hormone analogues for endometriosis: bone mineral density
- Levonorgestrel-releasing IUS effective for menorrhagia
- Metformin for hirsutism
- Management of adverse effects of radiotherapy
- Bariatric surgery (obesity surgery)
- Combined oral contraceptive pills (COCs) for treatment of acne
- Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution: Cochrane systematic review
- Polycystic ovary syndrome (PCOS)
- Vulvovaginitis
- Adverse effects of antineoplastic agents
- Ovarian cancer and hormone replacement therapy
- Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding
- Systemic lupus erythematosus (SLE)
- Nipple discharge and mastitis in a non-lactating woman
- Gynaecological cancers
- Gonadotrophin‐releasing hormone antagonists for assisted reproductive technology
- Hormone therapy in postmenopausal women and risk of endometrial hyperplasia
- AHA/ACC guideline for the primary prevention of stroke
- Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism
- Spinal manipulation for dysmenorrhoea
- Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder
- Levonorgestrel‐releasing intrauterine device (LNG‐IUD) for symptomatic endometriosis following surgery
- Combined oral contraceptive pill for primary dysmenorrhoea
- Interventions for hirsutism (excluding laser and photoepilation therapy alone)
- Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism
- Long‐term GnRH agonist therapy before in vitro fertilisation (IVF) for improving fertility outcomes in women with endometriosis
- Deep vein thrombosis
- Female sterilisation